Wealthfront Advisers
ABMD

Wealthfront Advisers’s Abiomed Inc ABMD Stock Holding History

Wealthfront Advisers’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,092
Closed -$1.5M – 804
2022
Q3 		$1.5M Buy
6,092
+376
+7% +$102K 0.01% 421
2022
Q2 		$1.42M Sell
5,716
-655
-10% -$177K 0.01% 435
2022
Q1 		$2.11M Buy
6,371
+622
+11% +$191K 0.01% 389
2021
Q4 		$2.06M Sell
5,749
-210
-4% -$71K 0.01% 380
2021
Q3 		$1.94M Buy
5,959
+94
+2% +$31.8K 0.01% 359
2021
Q2 		$1.83M Sell
5,865
-2,788
-32% -$855K 0.01% 321
2021
Q1 		$2.76M Buy
8,653
+2,151
+33% +$688K 0.01% 199
2020
Q4 		$2.11M Sell
6,502
-175
-3% -$48.4K 0.01% 216
2020
Q3 		$1.85M Buy
6,677
+556
+9% +$160K 0.01% 200
2020
Q2 		$1.48M Buy
+6,121
New +$1.23M 0.01% 232
2019
Q2 		– Sell
-2,210
Closed -$631K – 507
2019
Q1 		$631K Sell
2,210
-303
-12% -$101K 0.01% 331
2018
Q4 		$817K Buy
+2,513
New +$873K 0.01% 277

Other funds holding ABMD

TRSOTSOK
Teachers Retirement System of the State of Kentucky Frankfort, Kentucky $12.9B AUM 31.03% 1-Year Est. Return
BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
DekaBank Deutsche Girozentrale
DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return
Rockefeller Capital Management
Rockefeller Capital Management New York $56.4B AUM 24.96% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return
AW
Avion Wealth The Woodlands, Texas $484M AUM 15.17% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Wealthfront Advisers's ABMD Position: Q4 2022 in Review

Wealthfront Advisers sold out of Abiomed Inc (ABMD) in Q4 2022, closing a stake of 6,092 shares — an estimated $1.5M sold.

Wealthfront Advisers first reported a position in ABMD in Q4 2018 and held it in 12 quarters. The position peaked at $2.76M in Q1 2021. 8 funds tracked by Wall St. Rank hold ABMD as of Q4 2022.

  • Wealthfront Advisers reported no remaining Abiomed Inc position as of Q4 2022 after selling out during the quarter.
  • Wealthfront Advisers sold 6,092 Abiomed Inc shares in Q4 2022, an estimated $1.5M.
  • Wealthfront Advisers first reported a position in Abiomed Inc in Q4 2018 and held it in 12 quarters.
  • Wealthfront Advisers's Abiomed Inc position peaked at $2.76M in Q1 2021.
  • 8 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2022.

Based on Wealthfront Advisers's 13F filing for Q4 2022, filed 10 Feb 2023.